![William Duke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Duke
Financieel Directeur/CFO bij
INVIVYD, INC.
Vermogen: 161 335 $ op 31-08-2026
Profiel
William E.
Duke is Chief Financial & Accounting Officer at Invivyd, Inc. since 2023.
Former roles include Chief Financial Officer at OTF Group, Inc.; Director-Finance & Accounting at Haemonetics Corp.
from 2008 to 2010; Senior Director-Finance at Genzyme Corp.
from 2010 to 2011; Chief Financial Officer at g8wave Holdings, Inc. from 2007 to 2008; Chief Financial Officer & Head-Investor Relations at Valeritas, Inc. in 2015; Chief Financial Officer, Secretary & Treasurer at Pulmatrix, Inc. from 2015 to 2019; Chief Financial & Accounting Officer at Kaleido Biosciences, Inc. from 2019 to 2022; and Chief Financial Officer at Apexigen, Inc. from 2022 to 2023.
Education includes an MBA from Bentley University and undergraduate studies at Stonehill College, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INVIVYD, INC. 0,06% | 18-08-2026 | 168.937 ( 0,06% ) | 161 335 $ | 31-08-2026 |
Actieve functies van William Duke
| Bedrijven | Functie | Begin |
|---|---|---|
| INVIVYD, INC. | Financieel Directeur/CFO | 01-09-2023 |
Eerdere bekende functies van William Duke
| Bedrijven | Functie | Einde |
|---|---|---|
| APEXIGEN, INC. | Financieel Directeur/CFO | 23-08-2023 |
| KALEIDO BIOSCIENCES, INC. | Financieel Directeur/CFO | 08-04-2022 |
| PULMATRIX, INC. | Financieel Directeur/CFO | 22-11-2019 |
| VALERITAS INC | Financieel Directeur/CFO | 01-06-2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Financieel Directeur/CFO | - |
Opleiding van William Duke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Haemonetics Corp.
 Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
g8wave Holdings, Inc.
 g8wave Holdings, Inc. Specialty TelecommunicationsCommunications Provides planning, creating and executing effective mobile marketing campaigns and content distribution strategies | Communications |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OTF Group, Inc.
 OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
